A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
Ichiro Ikushima1, Kazuchika Yonenaga1, Hironao Iwakiri2, Hideki Nagoshi2, Haruhito Kumagai2, Yasuyuki Yamashita31Department of Radiology, 2Department of Cardiology, Miyakonojo Medical Association Hospital, Miyakonojo, Japan; 3Department of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto Uni...
Enregistré dans:
Auteurs principaux: | Ikushima I, Yonenaga K, Iwakiri H, Nagoshi H, Kumagai H, Yamashita Y |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d7edb3373e7d4400aadbafec2ac11df3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent
par: Litsky J, et autres
Publié: (2014) -
Carotid artery stenting: current and emerging options
par: Morr S, et autres
Publié: (2014) -
Updates on the use of ureteral stents: focus on the Resonance® stent
par: Thomas MT Turk, et autres
Publié: (2010) -
Everolimus-eluting coronary stents
par: Alejandro Saez, et autres
Publié: (2010) -
Advances in drug eluting stents – focus on the Endeavor® zotarolimus stent
par: Jonathan Bridges, et autres
Publié: (2008)